Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
SAG - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
PreventionGenetics, part of Exact Sciences United States | 285 | 137 |
|
Invitae Congenital Stationary Night Blindness Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 36 | 22 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Invitae Inherited Retinal Disorders Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 486 | 293 |
|
Molecular Vision Laboratory United States | 342 | 268 |
|
PreventionGenetics, part of Exact Sciences United States | 91 | 82 |
|
Autosomal Recessive Retinitis Pigmentosa (RP) Panel PreventionGenetics, part of Exact Sciences United States | 62 | 60 |
|
Oguchi Disease and Retinitis Pigmentosa (RP47) via the SAG Gene PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
SAG Deletion/Duplication Analysis Baylor Genetics United States | 2 | 1 |
|
SAG Comprehensive - Sequence & Deletion/Duplication Analysis Baylor Genetics United States | 2 | 1 |
|
SAG Sequence Analysis (Prenatal Diagnosis) Baylor Genetics United States | 2 | 1 |
|
Baylor Genetics United States | 2 | 1 |
|
Congenital stationary night blindness panel. 17-gene NGS panel. Genologica Medica Spain | 25 | 17 |
|
Genologica Medica Spain | 164 | 108 |
|
Retinal dystrophy panel. 260 gene NGS panel. Genologica Medica Spain | 420 | 257 |
|
SAG Sequence Analysis (Familial Mutation/Variant Analysis) Baylor Genetics United States | 1 | 1 |
|
Retinitis pigmentosa: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 75 | 71 |
|
Congenital Stationary Night Blindness NGS Panel Fulgent Genetics United States | 27 | 17 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.